Thromboxane production and platelet aggregation in type 2 diabetes mellitus without vascular complications
โ Scribed by Ratzmann, K. P. ;Schimke, E. ;Beitz, A. ;Hildebrandt, R. ;Taube, C.
- Publisher
- Springer-Verlag
- Year
- 1991
- Tongue
- English
- Weight
- 467 KB
- Volume
- 69
- Category
- Article
- ISSN
- 1432-1440
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The soluble form of the vascular cell adhesion molecule-1 (VCAM-1) is detectable in human sera and is elevated in diabetic patients, with unknown clinical significance. In the present study, the relationship between serum soluble VCAM-1 and diabetic microvascular complications (retinopathy, nephropa
We set out to determine the genotype distributions of the PI A polymorphism of platelet glycoprotein IIIa, the HPA-3 polymorphism of platelet glycoprotein IIb, and the variable number tandem repeat (VNTR) polymorphism of platelet glycoprotein Ib in subjects with Type 2 diabetes mellitus (Type 2 DM)
Persistent hyperglycaemia is the underlying pathogenic factor responsible for chronic diabetic complications in Type 1 and Type 2 diabetes mellitus. In Type 1 diabetes, diagnosis is made soon after the onset of hyperglycaemia and several years are required for the resultant complications to appear c
A possible association between plasma coagulant activity and the presence of vascular complications in patients with diabetes mellitus was studied by measuring the generation of thrombin in plasma of 20 control subjects and 50 diabetic patients classified according to the presence or absence of micr